Illumina’s boardroom intrigue, the next big Alzheimer’s readout, & J&J’s creative lawyers

Adam teaches Damian which months are part of Q2

April 7, 2023 Check out STAT+

Sponsored By

Is Illumina the Disney of biotech? Does the Texas two-step work after all? And can you ever really go home again? We cover all that and more this week on "The Readout LOUD," STAT's biotech podcast. Our colleague Matthew Herper joins us for a deep dive into Illumina, explaining how the biggest company in genome sequencing lost the faith of shareholders and painted itself into a corner. We'll also discuss the latest news in the life sciences, including a look at what's ahead in biotech for the second quarter of the year, and why Johnson & Johnson investors are happy the company is proposing to part with $9 billion. Listen Now Subscribe to the podcast to never miss an episode iTunes Spotify SoundCloud Stitcher TuneIn YouTube Visit the archive to see past episodes

---

---

Enjoying The Readout LOUD? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser